CTOs on the Move


 
Reveal allows you to virtually distribute reports, automatically secure them to the page level, extract critical data and easily maintain archived content. Replace your COLD/ERM software with a modern solution with Reveal!
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.opin.com
  • 7900, International Drive
    Bloomington, MN USA 55425
  • Phone: 952.567.2444

Executives

Name Title Contact Details

Similar Companies

Triplemint

The new standard of real estate. We use predictive analytics to anticipate the market and deliver the best matches to you. Make more informed real estate decisions by accessing our robust inventory of properties before they hit the market. Were with y...

G2

G2 is the world`s largest and most trusted marketplace to discover, review, and manage B2B software. More than 60 million people every year use G2 to make smarter software decisions based on authentic peer reviews, and thousands of companies of all sizes partner with G2 to build their reputation, manage their software spend, and grow their business. All of the FORTUNE 500 use G2, including Salesforce, Zoom, and Adobe.

2X Software

2X Software is a Addison, TX-based company in the Software and Internet sector.

Software2

The home of AppsAnywhere; the Higher Education application delivery, software deployment and virtualization solution delivering any app to any device.

Immunome

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.